Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
12/2008
12/31/2008EP2007358A2 Swellable particles for drug delivery
12/31/2008EP2007352A1 Treatment of psychiatric patients with sleep disturbances an/or excessive daytime sleepiness with paliperidone
12/31/2008EP2007349A1 Aerosol suspension formulations comprising tg 227 ea or tg 134 a as propellants
12/31/2008EP2007348A1 Paediatric amino acid solution for parenteral nutrition
12/31/2008EP2007227A2 Lycopene for the treatment of metabolic dysfunction
12/31/2008EP2007206A2 Method and composition for protecting neuronal tissue from damage induced by elevated glutamine levels
12/31/2008EP2007200A2 Products containing a pheromone component
12/31/2008EP1940231A4 Detection of lysophosphatidylcholine for prognosis or diagnosis of a systemic inflammatory condition
12/31/2008EP1928469A4 Fulvestrant formulation
12/31/2008EP1928431B1 Controlled release pharmaceutical composition containing carvedilol
12/31/2008EP1912641A4 Methods and compositions containing natural folates for protecting against radiation damage
12/31/2008EP1907530A4 Compositions and methods for treating tissue
12/31/2008EP1896489B1 Salts or complexes of methyl donors with phytic acid or its derivatives and method for the synthesis thereof
12/31/2008EP1855665B1 Use of phenylacetyl-derivatives for the manufacture of a medicament to treat von hippel-lindau (vhl) disease
12/31/2008EP1851198B1 Substituted pyrroles, compositions containing same, method for making same and use thereof
12/31/2008EP1841776B1 Decladinosyl-macrolides with anti-inflammatory activity
12/31/2008EP1802298B1 Novel agents for preventing and treating disorders connected to impaired neurotransmission
12/31/2008EP1776109B1 Pharmaceutical formulation comprising an antibiotic, a triazole and a corticosteroid
12/31/2008EP1765809B1 Xanthine derivatives useful as muscarinic receptor antagonists
12/31/2008EP1765404B1 Combinations comprising antimuscarinic agents and beta-adrenergic agonists
12/31/2008EP1737863B1 2-cyanopyrrolidinecarboxamides as dipeptidyl peptidase-iv inhibitors
12/31/2008EP1732926B1 Mitotic kinesin inhibitors
12/31/2008EP1727812B1 Novel cycloalkyl-containing 5-acylindolinones, their preparation and their use as pharmaceutical products
12/31/2008EP1694335A4 Osteoclastogenesis inhibitors and uses thereof
12/31/2008EP1689356B1 Topical compositions associating sodium hyaluronate fragments and retinoid
12/31/2008EP1684722B1 Medicamentously targeted local lipolysis
12/31/2008EP1680415B1 Pyrrolidinyl urea derivatives as angiogenesis inhibitors
12/31/2008EP1678181B1 A2b adenosine receptor antagonists
12/31/2008EP1648905B1 Thienopyridine and furopyridine kinase inhibitors
12/31/2008EP1638539B1 Pharmaceutical compositions comprising ph-sensitive block copolymers and a hydrophobic drug
12/31/2008EP1628659B1 Use of poly-aminopyrrolecarboxamides in combination with a cyclodextrin in the prophylaxis and treatment of animal parasitosis
12/31/2008EP1626727B1 Use of 2-cyano-10- (2-methyl-3- (methylamino)- propyl) phenothiazine or a pharmaceutically acceptable salt thereof as a medicament
12/31/2008EP1581219B1 Treatment of psychostimulant addiction
12/31/2008EP1569724B1 Formulations containing melatonin, ginkgo biloba, and biotin
12/31/2008EP1561820B1 Anthelmintic substance fki-1033 and process for producing the same
12/31/2008EP1558230B1 Spirocyclopropyl amides and acids and their therapeutic applications
12/31/2008EP1558202A4 Water soluble monomers and polymers for protecting subtrates from ultraviolet light
12/31/2008EP1546099B1 3,6-disubstituted azabicyclo 3.1.0 hexane derivatives useful as muscarinic receptor antagonists
12/31/2008EP1543013B1 5-[[(2,3-Difluorophenyl)methyl]thio]-7-[[2-hydroxy-1-(hydroxymethyl)-1-methylethyl]amino]thiazolo[4,5-d]pyrimidin-2(3H)-one monosodium salt as CXCR2 antagonist
12/31/2008EP1542974B1 5-[((2,3-difluorophenyl)methyl)thio]-7-{[(1S,2S)-2-hydroxy-1-(hydroxymethyl)propyl]amino}thiazolo[4,5-d]pyrimidin-2(3H)-one as CXCR2 antagonist
12/31/2008EP1535926B1 Carbacyclic phosphatidic acid derivative
12/31/2008EP1513922B1 Pasteurisation process for microbial cells and microbial oil
12/31/2008EP1507775B1 Heterocyclic compounds which inhibit leukocyte adhesion mediated by alpha4 integrins
12/31/2008EP1501501B1 Method for oxygen treatment of unsaturated carbon compounds, novel epoxy-structured material obtained by the method, apparatus for carrying out the method and a therapeutic composition using the material
12/31/2008EP1494685B1 Method of treating arrhythmias comprising administration of an a1 adenosine agonist with a beta blocker
12/31/2008EP1492506B1 Matrix for sustained, invariant and independent release of active compounds
12/31/2008EP1465610B1 Use of a gsk-3beta inhibitor in the manufacture of a medicament for increasing bone formation
12/31/2008EP1455817B1 Staphylococcus aureus exopolysaccharide and process
12/31/2008EP1437137B1 Drugs comprising combination of antithrombotic agent with pyrazolone derivative
12/31/2008EP1436264B1 Arylsulfanyl and heteroarylsulfanyl derivatives for treating pain
12/31/2008EP1416842B1 Pharmaceutical combinations of oxycodone and naloxone
12/31/2008EP1413332B1 Use of 2,5-dihydroxybenzenesulphonic acid derivatives in the production of a medicament used to potentiate the effect of other drugs in the treatment of erectile dysfunction
12/31/2008EP1409483B1 Arylsulfonamide derivatives as c-jun-n-terminal kinases (jnk's) inhibitors
12/31/2008EP1406867B1 Thiolalkyl benzoic acid derivatives
12/31/2008EP1402788B1 Body temperature-raising agent of amino acids for eating or drinking and for medical use
12/31/2008EP1392261B1 Delivery of nonsteroidal antiinflammatory drugs through an inhalation route
12/31/2008EP1364957B1 Glycopyranosyloxypyrazole derivatives and medicinal use thereof
12/31/2008EP1341512B1 Rhinological agents
12/31/2008EP1324756B1 Fatty acid analogues for the treatment of proliferative skin disorders
12/31/2008EP1322220A4 Methods for analyzing and using data from hypertensive patients
12/31/2008EP1317262A4 Topically applied hoof treatment composition concentrate
12/31/2008EP1309587B1 Cinnoline compounds
12/31/2008EP1296672B1 Stable pharmaceutical product and formulation
12/31/2008EP1283735B1 Method for the improvement of islet signaling in diabetes mellitus and for its prevention
12/31/2008EP1268525B1 Macrocyclic ns3-serine protease inhibitors of hepatitis c virus comprising n-cyclic p2 moieties
12/31/2008EP1255850B1 Amplification of cyp24 and uses thereof
12/31/2008EP1218001B1 Ultrafine l-carnitine, methods of preparing the same, compositions containing the same, and methods of using the same
12/31/2008EP1212339B1 2'-o-acetamido modified monomers and oligomers
12/31/2008EP1203239B1 Use of a polypeptide for detecting a pathological condition associated with multiple sclerosis
12/31/2008EP1192125B1 Mono-substituted 3-propyl gamma-aminobutyric acids
12/31/2008EP1102588B1 Pharmaceutical compositions for the prevention and treatment of central nervous system disorders comprising a nicotine analog and an acetylcholinesterase inhibitor
12/31/2008EP0989863B1 System for the in vivo delivery and expression of heterologous genes in the bone marrow
12/31/2008EP0968716B1 Drugs for ameliorating ocular circulatory disorders
12/31/2008EP0937153B1 Human monoclonal antibodies specific for hepatitis c virus (hcv) e2 antigen
12/31/2008CN101336253A Chitin derivatives for hyperlipidemia
12/31/2008CN101336247A Antiviral nucleosides
12/31/2008CN101336244A 9-membered heterobicyclic compounds as inhibitors of protein kinases
12/31/2008CN101336243A Lactam compounds and methods of using the same
12/31/2008CN101336239A Substituted oxindol-derivatives, medicaments containing said derivatives and use thereof
12/31/2008CN101336238A Novel 3-bicyclocarbonylaminopyridine-2-carboxamides or 3-bicyclocarbonylaminopyrazine-2-carboxamides
12/31/2008CN101336237A Pyrimidinyl aryl urea derivatives being fgf inhibitors
12/31/2008CN101336236A Anthranilic acid derivatives useful in treating infection with hepatitis c virus
12/31/2008CN101336235A 1-orthofluorophenyl substituted 1, 2, 5-thiazolidinedione derivatives as ptp-as inhibitors
12/31/2008CN101336233A Chemical derivatives of jasmonate, pharmaceutical compositions and methods of use thereof
12/31/2008CN101336230A Pharmaceutical for use in the treatment of ureterolithiasis
12/31/2008CN101336229A 改性的拟赖氨酸化合物 Proposed modification of lysine compound
12/31/2008CN101336227A Nuclear receptor binding agents
12/31/2008CN101336226A Substituted phenethylamines with serotoninergic and/or norepinephrinergic activity
12/31/2008CN101336113A Pharmaceutical comprising PPAR agonist
12/31/2008CN101336109A Method and composition for treating and diagnosing restless legs syndrome
12/31/2008CN101336108A Composition containing oligosaccharides for the treatment / prevention of infections
12/31/2008CN101336107A Methods for improving the pharmacokinetics of HIV integrase inhibitors
12/31/2008CN101336106A Use of benzo-fused heterocycle sulfamide derivatives for the treatment of depression
12/31/2008CN101336105A Oxcarbazepine pharmaceutical formulation and its method of preparation, wherein oxcarbazepine has a broad and multi-modal particle size distribution
12/31/2008CN101336077A Use of 25-hydroxy vitamin D3 to improve vitality of animals
12/31/2008CN101334356A Gas sensors
12/31/2008CN101333530A Apoptosis-associated gene and medicaments for treating leucocythemia using the gene as target
12/31/2008CN101333529A SiRNA sequence against HCMV UL122 gene and applications
12/31/2008CN101333528A SiRNA sequence for HCMV UL122 gene and applications
12/31/2008CN101333527A SiRNA sequence of human cytomegalovirus UL122 gene and applications
1 ... 2928 2929 2930 2931 2932 2933 2934 2935 2936 2937 2938 2939 2940 2941 2942 2943 2944 2945 2946 2947 2948 ... 7860